Santen Pharmaceutical Co., Ltd. financial statements, including revenue, expenses, profit, and loss

The total revenue of SNPHY for the last quarter is 479.83 M USD, and it's 9.97% lower compared to the previous quarter. The net income of Q1 24 is 68.24 M USD.